Louisiana SB 278: PHARMACEUTICALS: Provides relative to the maximum cost of prescription insulin drugs. (8/1/22)

Status: Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Insurance. (as of 2022-03-14)

State: Louisiana · Session: 2022 · Bill: SB 278

Sponsors: Fred H. Mills, Jr.

View Louisiana SB 278 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.